Topiramate pharmacokinetics in infants

Epilepsia

Volumn 40, Issue 6, 1999, Pages 788-791

  Glauser, Tracy A ^a   Miles, Michael V ^a   Tang, Peter ^a   Clark, Peggy ^a   McGee, Kathy ^a   Doose, Dennis R ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Enzyme inducing agents; Pharmacokinetics; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; DRUG METABOLIZING ENZYME; TOPIRAMATE;

AGE; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; HUMAN; INFANTILE SPASM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0033052686     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00780.x     Document Type: Article

References (14)

1. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600mg daily dosages: Topiramate YD Study Group. Neurology 1996;46:1684-90.
2. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800, and 1,000mg daily dosages: Topiramate YE Study Group. Neurology 1996;46:1678-83.
3. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
4. BenMenachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
5. Pledger G, Reife R, Lim P. Topiramate: intent-to-treat and other analyses. Epilepsia 1996;37:72.
6. Reife RA, Pledger G, Lim P. Topiramate: pooled analysis of six placebo-controlled trials. Epilepsia 1996;37:74.
7. Elterman R, Glauser TA, Ritter FJ, Reife R, ShuChen W. Efficacy and safety of topiramate in partial seizures in children. Neurology 1997;48:1729.
8. Biton V, Chadwick D, Montouris GD, Wu SC. Topiramate as long-term therapy in patients with generalized tonic-clonic seizures without focal onset. Neurology 1998;50(suppl 4):A311-2.
9. Glauser TA, Sachdeo RC, Ritter FJ, Reife R, Lim P. Topiramate in Lennox-Gastaut syndrome: a double-blind trial. Neurology 1997; 48:1729.
10. Glauser TA. Topiramate. Semin Pediatr Neurol 1997;4:3442.
11. Cloyd JC, Birnbaum AK, Kriel RL. Pharmacokinetics in infancy, childhood, and adolescence. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. Baltimore: Williams & Wilkins, 1996:737-46.
12. Product insert supplement. Innofluor topiramate procedure. Portland, OR: Oxis International, 1997.
13. Anonymous. Noncompartmental analysis: users guide for Win-Nonlin, version 1.5. Cary, NC: Scientific Consulting, 1997.
14. Rosenfeld WE, Doose DR, Walker SA. The steady-state pharmacokinetics of topiramate as adjunctive therapy in pediatric subjects with epilepsy. Epilepsia 1995;36(suppl 3):158.